Bioxcel Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.15

-0.06 (-4.96%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 1 9%

Sell 1 9%

Price Target

Analyst Price Target +1,809.6% upside

Low Target $14.05

Average Target $21.96

High Target $26.87

Current Price $1.15

Current
$1.15

Target
$21.96

$14.05 $21.96 avg $26.87

Scenario Analysis

Bear Case

$14.05

1,121.7%

Low target

Base Case

$21.96

+1,809.6%

Avg target

Bull Case

$26.87

+2,236.5%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$8.08

-85.8% from high

52-Week Low

$1.01

+13.9% from low

Target vs 52W High

$21.96

+171.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%